Advanced Treatment Options
Access to new therapies and medications before they are widely available to the public.
Compassionate care, advanced medicine, trusted results — patient first. Our Clinical Trials Department works to discover safer, more effective ways to prevent, diagnose and treat disease. By bridging laboratory science and patient care, we offer our community early access to tomorrow's medical breakthroughs today.

Meera Hospitals has conducted clinical trials since 2017 under a CDSCO-registered Institutional Ethics Committee, with a trained research team and a documented patient population across 18+ specialities.
Considering taking part in a study, or asked about one by your doctor.
Before they are widely available.
Ethics committee oversight and GCP standards.
Study medication, tests and visits are generally covered.
Evaluating Meera Hospitals as a site for an upcoming trial.
Nine trials completed, one ongoing.
Roughly 8,300+ patients across 18+ specialities.
Streamlined institutional review timelines.
Participating in a clinical trial is a profound contribution to modern medicine. As a participant at Meera Hospitals, you receive:
Access to new therapies and medications before they are widely available to the public.
Close monitoring by a dedicated team of leading physicians, researchers and healthcare professionals.
The opportunity to help future generations by contributing to vital scientific discoveries.
Every clinical trial at Meera Hospitals undergoes a rigorous review process and is strictly monitored by an Institutional Ethics Committee.
We adhere to Good Clinical Practice (GCP) guidelines and international regulatory standards, so that the rights, safety and confidentiality of every participant are protected at all times. Participation is entirely voluntary, and patients may choose to withdraw from a study at any stage.
Re-registered by CDSCO under the New Drugs and Clinical Trials Rules, 2019. Valid 09 Mar 2026 – 08 Mar 2031.
No study begins without ethics committee approval.
You decide, after the study is explained in full.
Your ongoing clinical care is never affected.
Meera Hospitals is a preferred site for clinical research — with state-of-the-art diagnostics, secure investigational product storage, and a diverse, well-documented patient pool.
Each hexagon is one clinical trial.
Nine trials completed and one ongoing. Phase I studies are within the site's capability but none has been conducted to date.
| Phase | Completed | Ongoing |
|---|---|---|
| Phase II | 1 | 0 |
| Phase III | 3 | 0 |
| Phase IV | 5 | 1 |
Patients available for screening. Approximate figures.
Approximately 8,300+ patients in total. Figures are indicative of the population available for screening, not of subjects enrolled in trials.
| Speciality | Patients |
|---|---|
| Diabetology | 2,000+ |
| Pediatrics | 1,500+ |
| Gynaecology | 1,000+ |
| Cardiology | 1,000+ |
| Orthopaedics | 800+ |
| Gastroenterology | 500+ |
| Psychiatry | 500+ |
| Neurology | 400+ |
| Oncology | 300+ |
| Nephrology | 300+ |
| Urology | 300+ |
| Cosmetology | 200+ |
State-of-the-art diagnostic facilities and secure investigational product storage.
Across 18+ specialities, with a computerised pathology lab running 24 hours.
Principal Investigators, study coordinators and ICH-GCP-certified staff.
Streamlined institutional review and ethical approval.
Photographs to be added; initials shown in the interim.
Overall responsibility for clinical research conduct and sponsor liaison.
96193 89849Site Clinical Research Coordinator — day-to-day study conduct and patient screening.
95583 20929For feasibility questionnaires, site qualification visits and upcoming trials.
meeraresearch1@gmail.comA scientific study designed to test how well a new medical approach, drug, or device works in human volunteers.
Each study has specific criteria (like age, gender, or medical history) called inclusion and exclusion criteria. Our research team will guide you through a screening process to see if a trial is a safe fit for you.
In most clinical trials, the study medication, medical tests, and doctor visits related to the trial are provided at no cost to the participant.
Sponsors and CROs are welcome to request our site feasibility pack. Patients can ask their treating consultant, or reach the research team directly.